Search Grant Opportunities

DoW Reconstructive Transplant, Investigator-Initiated Research Award

ID: HT942526RTRPIIRA • Type: Posted
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Sign in to upload a capability statement or catalogue for your company

Analyze Opportunity
Generate a Draft
Loading

Description

Posted:

Summary: The fiscal year 2026 (FY26) Reconstructive Transplant Research Program (RTRP) Investigator-Initiated Research Award supports studies that have the potential to make an important contribution to reconstructive transplant research, patient care, and/or quality of life. All projects must demonstrate solid scientific rationale with military-relevant utility. The Investigator-Initiated Research Award does not support clinical trials.

Distinctive Features:

Scope: Applications may focus on any phase of research from basic through translational, including preclinical studies in animal models, and clinical research in human subjects or human anatomical substances.

Study Design and Feasibility: The study design should be rigorous and support maximal reproducibility and translational feasibility. A strong statistical plan with appropriate power analysis is important.

Impact: Project results should have the potential for long- and short-term impact on the reconstructive transplant research field and/or patient community. Projects should address at least one of the FY26 RTRP Focus Areas.

Preliminary Data: Preliminary and/or published data that are relevant to reconstructive transplantation and support the rationale for the proposed research must be included.

Military Relevance: All projects must be responsive to the health care needs of military Service Members and/or Veterans recovering from traumatic injury, and/or their Family members, caregivers, or clinicians, as well as the general public. Collaboration with military researchers and clinicians is encouraged but not required.

Posted:
Posted:
Background
The fiscal year 2026 (FY26) Reconstructive Transplant Research Program (RTRP) Investigator-Initiated Research Award supports studies that have the potential to make significant contributions to reconstructive transplant research, patient care, and quality of life.

The program is managed by the Congressionally Directed Medical Research Programs (CDMRP) within the Defense Health Agency, which aims to refine approaches for and increase access to reconstructive transplants and state-of-the-art immunotherapy.

The RTRP was initiated by Congress in 2012 and has a total appropriation of $12 million for FY26.

Grant Details
The Investigator-Initiated Research Award supports studies across all phases of research from basic through translational, including preclinical studies in animal models and clinical research involving human subjects or anatomical substances.

Key elements include:
- A rigorous study design that supports reproducibility and feasibility, including a strong statistical plan with power analysis.
- Projects must demonstrate potential long-term impacts on the reconstructive transplant field or patient community and address at least one FY26 RTRP Focus Area.
- Inclusion of preliminary data relevant to reconstructive transplantation is mandatory.
- All projects must be responsive to the healthcare needs of military Service Members, Veterans, their families, caregivers, or clinicians. Collaboration with military researchers is encouraged but not required.

Eligibility Requirements
Eligible applicants include extramural and intramural U.S. Department of War organizations, both foreign and domestic, for-profit and nonprofit organizations, as well as public or private entities. Independent investigators at all career levels affiliated with eligible organizations can serve as Principal Investigators (PIs). An investigator may be named on only two FY26 RTRP applications as PI.

Period of Performance
The maximum period of performance for awarded projects is three years.

Grant Value
The CDMRP expects to allocate approximately $8 million to fund around eight Investigator-Initiated Research Award applications, with a total cost cap of $1 million per award.

Overview

Category of Funding
Science and Technology and other Research and Development
Funding Instruments
Grant
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 8/26/26 U.S. Army Medical Research Acquisition Activity posted grant opportunity HT942526RTRPIIRA for DoW Reconstructive Transplant, Investigator-Initiated Research Award with funding of $8.0 million. The grant will be issued under grant program 12.420 Military Medical Research and Development. It is expected that 8 total grants will be made.

Timing

Posted Date
Closing Date
Due in 21 Days
Last Updated
Version
1
Archive Date

Eligibility

Eligible Applicants
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

Award Sizing

Ceiling
Not Listed
Floor
Not Listed
Estimated Program Funding
$8,000,000
Estimated Number of Grants
8

Contacts

Contact
Teresa M Parker-Reeser Grants Officer
Contact Email
Email Description
eBRAP Help Desk
Contact Phone
(301) 619-2171

Documents

Posted documents for HT942526RTRPIIRA

Opportunity Assistant


Analyze Opportunity

Generate a Draft

Potential Applicants and Partners

Awardees that have recently won grants similar to HT942526RTRPIIRA

Incumbent or Similar Grants

Grants similar to HT942526RTRPIIRA

Similar Active Opportunities

Open grant opportunities similar to HT942526RTRPIIRA

Experts for DoW Reconstructive Transplant, Investigator-Initiated Research Award

Recommended subject matter experts available for hire